Correction to: An integrative pan-cancer analysis of biological and clinical impacts underlying ubiquitin-specific-processing proteases
Di Chen(First Affiliated Hospital of Zhengzhou University), Hai-long Piao(Dalian Institute of Chemical Physics), Tian Xia(Dalian Institute of Chemical Physics), Huan Qi(Qingdao Institute of Bioenergy and Bioprocess Technology), Chang Lu(Central South University), Xin Guo(Ganzhou People's Hospital), Xiumei Liu(Dalian University of Foreign Languages), Jing Liu(Hebei Medical University), Xiaolong Liu(Tianjin University of Technology and Education), Wen Wang(Queen Mary University of London), Zhen Ning(Dalian Medical University), Huan Chen(Zhejiang Chinese Medical University), Ting Ling(Dalian Institute of Chemical Physics), Ji-Wei Liu(Dalian Institute of Chemical Physics), Qiu Yan(Dalian Medical University), Ji-Wei Liu(Dalian Institute of Chemical Physics), Aman Wang(Dalian Medical University), Dinesh Singh Tekcham(Dalian Institute of Chemical Physics), Jing Liu(Dalian Institute of Chemical Physics), Guang Tan(Tongji Hospital)
Cited by 0
Related Papers
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
|Cellular and Molecular Immunology|2020|376
EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis
|Nature Cell Biology|2022|186